An adjuvant-containing cDC1-targeted recombinant fusion vaccine conveys strong protection against murine melanoma growth and metastasis

Volume 11, Issue 1, December 2022 .

Source: OncoImmunology - August 25, 2022 Category: Cancer & Oncology Authors: Mohammad Arabpour Sanchari Paul Hanna Grauers Wiktorin Mustafa Kaya Roberta Kiffin Nils Lycke Kristoffer Hellstrand Anna Martner Source Type: research